Investview, Inc. Reports Third-Quarter 2026 Financial Results and Strategic Business Update

Haverford, PA, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU) (the “Company”) today reported financial results for the third quarter ended September 30, 2026, and provided an update on operating activity during the quarter. The quarter reflected a continued contraction in the Company's marketing network, a 10% increase in revenue from its health, beauty, and wellness businesses versus the second quarter of 2026, and continued investment in pre-commercial operations. Net income for the quarter was $9.0 million versus a $3.2 million loss in the second quarter of 2026, primarily attributable to the sale of the Company’s equity investment in an early-stage nuclear power and infrastructure technology company. The sale generated $10.8 million in net cash proceeds, strengthening the Company's financial position while its operating businesses continued to face challenges. Management will continue to focus on simplifying the portfolio, strengthening capital-allocation discipline, and clarifying the roles of its operating businesses, including selective commercial integration among Conectiv, MyLife Wellness, and Renu Laboratories.